Cytosorbents Corp (CTSO)

Finanzdaten der Cytosorbents Corp-Aktie (CTSO)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	12.90% 9.7863	8.6682	8.8108	9.4208	9.4495
Cost Of Revenue	4.21% 3.2157	3.3569	3.204	3.4023	3.9942
Gross Profit	23.71% 6.5706	5.3113	5.6069	6.0186	5.4553
Operating Expenses	21.90% 11.50	14.72	12.96	12.58	13.35
Benefits Costs and Expenses	16.14	-	-	-	-
Costs And Expenses	10.69% 16.14	18.08	16.16	15.98	17.34
Depreciation and Amortization	0.67% 0.3973	0.3946	0.4072	0.402	0.2586
Operating Income/Loss	47.65% -4.9255	-9.4082	-7.3502	-6.5592	-7.8916
Nonoperating Income/Loss	153.19% -1.4323	2.6928	-1.8433	0.4062	0.5657
Income/Loss From Continuing Operations Before Tax	173.35% -6.3579	8.6682	-9.1935	-6.1531	-7.3259
Income/Loss From Continuing Operations After Tax	8.96% -6.3579	-5.8349	-9.1935	-6.1531	-7.3259
Net Income/Loss	8.96% -6.3579	-5.8349	-9.1935	-6.1531	-7.3259
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	8,487% 54.26	0.6319	44.37	44.02	43.68
Diluted Average Shares	8,487% 54.26	0.6319	44.37	44.02	-0.2565
Basic Earnings Per Share	0.00% -0.12	-0.12	-0.21	-0.14	-0.17
Diluted Earnings Per Share	0.00% -0.12	-0.12	-0.21	-0.14	-0.17
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-